{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:35:04Z","timestamp":1789792504333,"version":"4.0.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210287","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T14:27:42Z","timestamp":1548858462000},"page":"e0210287","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Factors affecting mortality among HIV positive patients two years after completing recommended therapy for Cryptococcal meningitis in Uganda"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-4037","authenticated-orcid":true,"given":"Jonathan","family":"Kitonsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-1818","authenticated-orcid":true,"given":"Yunia","family":"Mayanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Aling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9442-1719","authenticated-orcid":true,"given":"Julius","family":"Kiwanuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Namutundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacchaeus","family":"Anywaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu-Baker","family":"Ggayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9512-1571","authenticated-orcid":true,"given":"Freddie","family":"Kibengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Kiwanuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pontiano","family":"Kaleebu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"R Rajasingham","year":"2017","journal-title":"The Lancet Infectious Diseases"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/313910","article-title":"Bacterial Meningitis in Malawian Adults: Pneumococcal Disease is Common, Severe, and Seasonal","volume":"31","author":"SB Gordon","year":"2000","journal-title":"Clinical Infectious Diseases"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"BJ Park","year":"2009","journal-title":"AIDS"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination Antifungal Therapy for Cryptococcal Meningitis","volume":"368","author":"JN Day","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy","volume":"46","author":"A Kambugu","year":"2008","journal-title":"Clinical Infectious Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S38850","article-title":"Cryptococcal meningitis: epidemiology and therapeutic options","volume":"6","author":"DJ Sloan","year":"2014","journal-title":"Clin Epidemiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s40588-016-0035-5","article-title":"HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings","volume":"3","author":"MW Tenforde","year":"2016","journal-title":"Current Clinical Microbiology Reports"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/QAI.0b013e3181a56f2e","article-title":"Immune Reconstitution Inflammatory Syndrome in HIV-Associated Cryptococcal Meningitis: A Prospective Study","volume":"51","author":"T Bicanic","year":"2009","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1745-6215-15-441","article-title":"CryptoDex: A randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a randomised control trial","volume":"15","author":"J Day","year":"2014","journal-title":"Trials"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/CLEP.S38850","article-title":"Cryptococcal meningitis: epidemiology and therapeutic options","volume":"6","author":"DJ Sloan","year":"2014","journal-title":"Clinical Epidemiology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol-a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health policy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cct.2015.05.015","article-title":"Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design","volume":"43","author":"Z Anywaine","year":"2015","journal-title":"Contemporary Clinical Trials"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e51291","DOI":"10.1371\/journal.pone.0051291","article-title":"Long Term 5-Year Survival of Persons with Cryptococcal Meningitis or Asymptomatic Subclinical Antigenemia in Uganda","volume":"7","author":"EK Butler","year":"2012","journal-title":"PLOS ONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-155-4-201108160-00358","article-title":"Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: A cohort analysis from uganda","volume":"155","author":"EJ Mills","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome","volume":"337","author":"CM van der Horst","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"CK Muzoora","year":"2012","journal-title":"Journal of Infection"},{"key":"ref17","article-title":"Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings","author":"D Sloan","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"ref18","first-page":"1363","article-title":"A Phase II Randomised Controlled Trial Adding Oral Flucytosine to High Dose Fluconazole, with Short-course Amphotericin B, for Cryptococcal Meningitis","volume":"26","author":"A Jackson","year":"2012","journal-title":"A Phase II Randomised Controlled Trial Adding Oral Flucytosine to High Dose Fluconazole, with Short-course Amphotericin B, for Cryptococcal Meningitis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the Early Fungicidal Activity of High-Dose Fluconazole, Voriconazole, and Flucytosine as Second-Line Drugs Given in Combination With Amphotericin B for the Treatment of HIV-Associated Cryptococcal Meningitis","volume":"54","author":"A Loyse","year":"2012","journal-title":"Clinical Infectious Diseases"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","article-title":"Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study","volume":"7","author":"DR Boulware","year":"2010","journal-title":"PLOS Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1177\/1055329004269478","article-title":"Clinical Sequelae Affecting Quality of Life in the HIV-Infected Patient","volume":"15","author":"S Davis","year":"2004","journal-title":"Journal of the Association of Nurses in AIDS Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1525-1497.2005.30402.x","article-title":"The Association of Health-related Quality of Life with Survival Among Persons with HIV Infection in the United States","volume":"20","author":"WE Cunningham","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis","volume":"374","author":"J Beardsley","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199102283240902","article-title":"A Placebo-Controlled Trial of Maintenance Therapy with Fluconazole after Treatment of Cryptococcal Meningitis in the Acquired Immunodeficiency Syndrome","volume":"324","author":"SA Bozzette","year":"1991","journal-title":"New England Journal of Medicine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:28:15Z","timestamp":1588962495000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210287"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210287","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]}}}